Search Results for 'astellas'
-
Promotions & Moves
Astellas Appoints Latin America VP
Fernandez responsible for leading operations and growth across Latin America08.24.18
-
Drug Development | Industry News
-
Bio News | Industry News | Promotions & Moves
Astellas Announces Management Changes
The changes include the positions of VP, Oncology, Medical Affairs, and VP, & executive director, Corporate Communications07.24.18
-
cGMP Manufacture | Collaborations & Alliances | Drug Development | Facilities | Industry News
Eurofins, Astellas Sign Outsourcing Agreement
Astellas has committed to provide ASL work covering its current capacity for an agreed period of time05.29.18
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Actinium, Astellas Form Research Partnership
Will utilize Actinium's AWE Technology Platform to generate Actinium Radio-Conjugates on selected Astellas targeting agents03.29.18
-
Promotions & Moves
Astellas Appoints Ethics & Compliance Head
Dragovic to oversee Ethics & Compliance efforts globally03.28.18
-
Drug Development | Trials & Filings
Astellas Achieves Breakthrough Designation for Urothelial Cancer ADC
Enfortumab vedotin is being evaluated in metastatic urothelial cancer in patients previously treated with CPIs03.26.18
-
Promotions & Moves
Astellas Pharma Names Americas Ops President
Barretto-Ko to lead the company's North and South America operations03.15.18
-
15 Astellas Pharma
#15 Astellas Pharma 2-3-11, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo, Japan 103-8411 Tel: (81) 3 3244 3000 Fax: (81) 3 3244 3272 www.astellas.com Headcount 17,085…Kristin Brooks 07.18.12
-
16 Astellas Pharma
#16. Astellas Pharma 3-11, Nihonbashi-honcho 2-chome, Chuo-ku Tokyo, 103-8411 Japan Tel: (81) 3 3244 3000 Fax: (81) 3 3244 3272 www.astellas.com Headcount 15,000 Year Established…07.12.06
